The epigenetic/noncoding origin of tumor dormancy

Trends in Molecular Medicine
Francesco CreaYuzhuo Wang

Abstract

Cancer stem cells (CSCs) have been implicated as the seeds of treatment resistance and metastasis, which are the most deadly features of a neoplasm. However, an unequivocal definition of the CSC phenotype is still missing. A common feature of normal and aberrant stem cells is their ability to enter a prolonged dormant state. Cancer dormancy is a key mechanism for treatment resistance and metastasis. Here we propose a unified definition of dormancy-competent CSCs (DCCs) as the neoplastic subpopulation that can plastically alternate periods of dormancy and rapid growth. Irreversible DNA mutations can hardly account for this versatile behavior, and based on emerging evidence we propose that cancer dormancy is a nongenetic disease driven by the flexible nature of the epigenetic/noncoding interactome.

References

Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Jun 5, 2002·Nature Reviews. Cancer·William C Hahn, Robert A Weinberg
Apr 3, 2003·Cancer Research·Julio A Aguirre-GhisoLiliana Ossowski
Jan 2, 2004·Breast Cancer Research and Treatment·George N NaumovAnn F Chambers
Jun 2, 2004·Nature Reviews. Cancer·Klaus Pantel, Ruud H Brakenhoff
Feb 24, 2006·Nature Reviews. Cancer·Stephen B Baylin, Joyce E Ohm
Jul 25, 2006·Cancer Biology & Therapy·Aparna C RanganathanJulio A Aguirre-Ghiso
Oct 25, 2007·Nature Reviews. Cancer·Julio A Aguirre-Ghiso
Apr 4, 2008·Clinical & Experimental Metastasis·Ann F Chambers
May 24, 2008·The Journal of Clinical Investigation·Sergey V ShmelkovShahin Rafii
May 27, 2010·The Journal of Clinical Investigation·Jo EylesJean-Pierre Abastado
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
May 3, 2011·Trends in Pharmacological Sciences·Francesco CreaRomano Danesi
May 31, 2011·Lancet·Audrey VincentMichael Goggins
Jul 13, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jonathan W Uhr, Klaus Pantel
Jul 16, 2011·International Journal of Technology Assessment in Health Care·Russell J BowaterRichard J Lilford
Jul 27, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Francesco CreaWilliam Farrar
Sep 29, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yinghua ZhuErwei Song
Nov 30, 2011·The Journal of Experimental Medicine·Aya KobayashiKounosuke Watabe
Dec 7, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Janine StutterheimC Ellen van der Schoot
Feb 7, 2012·Cell Stem Cell·Zhe Wang, Gaoliang Ouyang
Jul 4, 2012·Current Drug Targets·Julius SemenasJenny Liao Persson
Jul 10, 2012·Cell·Swarnali AcharyyaJoan Massagué
Sep 18, 2012·The American Journal of Pathology·Shujing LiuXiaowei Xu
Dec 12, 2012·Clinical Chemistry·Nemanja D MarjanovicChristine L Chaffer
Dec 26, 2012·European Urology·Johan LindbergHenrik Grönberg
Feb 26, 2013·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Natsue UehiroFutoshi Akiyama
Apr 25, 2013·Cancer Metastasis Reviews·Nazanin S RuppenderRobert L Vessella
Apr 30, 2013·Biochemical and Biophysical Research Communications·Shaobin WuYuxiang Chen
May 31, 2013·Science Translational Medicine·Roxanne ToivanenGail P Risbridger
Sep 12, 2013·Nature Reviews. Genetics·Ian R WatsonLynda Chin
Oct 19, 2013·Epigenetics : Official Journal of the DNA Methylation Society·Tianjiao LyuWeiwei Feng
Nov 12, 2013·Cell·Filippo G Giancotti
Dec 10, 2013·The Journal of Clinical Investigation·Lara H El TounyJeffrey E Green
Dec 19, 2013·Cancer Metastasis Reviews·Francesco CreaCheryl D Helgason
Mar 13, 2014·Cell Stem Cell·Antonija Kreso, John E Dick
Mar 13, 2014·Cell Stem Cell·Thordur OskarssonJoan Massagué
Mar 29, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Matthias IlmerEckhard Alt
May 13, 2014·International Journal of Hematology·Satoshi Yamazaki, Hiromitsu Nakauchi
Jun 25, 2014·Journal of the National Cancer Institute·Francesco SclafaniIan Chau

❮ Previous
Next ❯

Citations

Oct 23, 2015·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Colm MorrisseyHung-Ming Lam
Jul 18, 2015·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Annarosa Arcangeli, Andrea Becchetti
Nov 22, 2017·Oncotarget·Yuan-Chin Tsai, Yen-Nien Liu
Aug 23, 2019·Cancers·Rana Jahanban-EsfahlanPeyman Zare
Nov 12, 2019·Frontiers in Oncology·Hao-Ran SunQiong-Zhu Dong
Jun 4, 2020·Nature Reviews. Cancer·Tri Giang Phan, Peter I Croucher
Nov 17, 2020·Frontiers in Immunology·Antonella SistiguRuggero De Maria
Mar 30, 2021·Seminars in Cancer Biology·Kimberly A ParkerWilliam P Schiemann
Nov 12, 2018·Biochemical Pharmacology·François M ValletteDominique Heymann
Jun 3, 2021·International Journal of Molecular Sciences·Georgia GomatouElias A Kotteas
Nov 25, 2018·Seminars in Cancer Biology·Teresa Bernadette SteinbichlerIra-Ida Skvortsova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

© 2021 Meta ULC. All rights reserved